文献速递肝病

肝硬化患者门体分流与并发症及死亡率增加的相关性

Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis.
PubMed 文献 · Gastroenterology · 2018-01-31

这项回顾性研究纳入加拿大和欧洲14个中心的1729例肝硬化患者,分析自发性门体分流(SPSS)的患病率及临床影响。结果显示60%患者存在SPSS,其患病率随肝功能恶化而增加;SPSS与肝性脑病、门静脉高压相关并发症、生活质量下降及无移植生存率降低独立相关。

要点

  • 肝硬化患者中SPSS总体患病率为60%,其中大分流(≥8 mm)占28%,小分流(<8 mm)占32%。
  • SPSS的存在与大小随肝功能恶化而增加,MELD≥14组中大分流占40%。
  • SPSS是无死亡或肝移植的独立相关因素(HR 1.26,95%CI 1.06-1.49,P=.008)。

核心结论

  • 在近2000例肝硬化患者的回顾性分析中,60%存在SPSS,其患病率随肝功能恶化而增加;SPSS增加肝性脑病风险并呈慢性病程;在肝功能保留的患者中,SPSS增加并发症和死亡风险。

研究设计与样本

  • 回顾性研究纳入2010年至2015年加拿大和欧洲14个中心接受腹部CT或MRI分析的1729例肝硬化患者,根据SPSS大小分为大SPSS(≥8 mm)、小SPSS(<8 mm)和无SPSS组。

主要发现

  • 大SPSS占28%(488例),小SPSS占32%(548例),无SPSS占40%(693例);大SPSS中最常见为脾肾分流(占大SPSS的46%)。
  • 肝性脑病在大SPSS组占48%、小SPSS组占34%、无SPSS组占20%(P<.001);复发性或持续性肝性脑病分别占52%、44%和37%(P=.007)。
  • SPSS患者门静脉高压相关并发症(出血或腹水)数量多于无SPSS者,生活质量和无移植生存率低于无SPSS者。
  • 多因素分析中SPSS是与死亡或肝移植独立相关的因素(HR 1.26,95%CI 1.06-1.49,P=.008)。
  • 按MELD分层后,SPSS与肝性脑病的关联独立于肝功能:MELD 6-9组肝性脑病在大SPSS、小SPSS和无SPSS中分别占23%、12%和5%(P<.001);MELD 10-13组分别占48%、33%和23%(P<.001);MELD≥14组分别占59%、57%和48%(P=.043)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Spontaneous portosystemic shunts (SPSS) have been associated with hepatic encephalopathy (HE). Little is known about their prevalence among patients with cirrhosis or clinical effects. We investigated the prevalence and characteristics of SPSS in patients with cirrhosis and their outcomes. METHODS: We performed a retrospective study of 1729 patients with cirrhosis who underwent abdominal computed tomography or magnetic resonance imaging analysis from 2010 through 2015 at 14 centers in Canada and Europe. We collected data on demographic features, etiology of liver disease, comorbidities, complications, treatments, laboratory and clinical parameters, Model for End-Stage Liver Disease (MELD) score, and endoscopy findings. Abdominal images were reviewed by a radiologist (or a hepatologist trained by a radiologist) and searched for the presence of SPSS, defined as spontaneous communications between the portal venous system or splanchnic veins and the systemic venous system, excluding gastroesophageal varices. Patients were assigned to groups with large SPSS (L-SPSS, ≥8 mm), small SPSS (S-SPSS, <8 mm), or without SPSS (W-SPSS). The main outcomes were the incidence of complications of cirrhosis and mortality according to the presence of SPSS. Secondary measurements were the prevalence of SPSS in patients with cirrhosis and their radiologic features. RESULTS: L-SPSS were identified in 488 (28%) patients, S-SPSS in 548 (32%) patients, and no shunt (W-SPSS) in 693 (40%) patients. The most common L-SPSS was splenorenal (46% of L-SPSS). The presence and size of SPSS increased with liver dysfunction: among patients with MELD scores of 6-9, 14% had L-SPSS and 28% had S-SPSS; among patients with MELD scores of 10-13, 30% had L-SPSS and 34% had S-SPSS; among patients with MELD scores of 14 or higher, 40% had L-SPSS and 32% had S-SPSS (P < .001 for multiple comparison among MELD groups). HE was reported in 48% of patients with L-SPSS, 34% of patients with S-SPSS, and 20% of patients W-SPSS (P < .001 for multiple comparison among SPSS groups). Recurrent or persistent HE was reported in 52% of patients with L-SPSS, 44% of patients with S-SPSS, and 37% of patients W-SPSS (P = .007 for multiple comparison among SPSS groups). Patients with SPSS also had a larger number of portal hypertension-related complications (bleeding or ascites) than those W-SPSS. Quality of life and transplantation-free survival were lower in patients with SPSS vs without. SPSS were an independent factor associated with death or liver transplantation (hazard ratio, 1.26; 95% confidence interval, 1.06-1.49) (P = .008) in multivariate analysis. When patients were stratified by MELD score, SPSS were associated with HE independently of liver function: among patients with MELD scores of 6-9, HE was reported in 23% with L-SPSS, 12% with S-SPSS, and 5% with W-SPSS (P < .001 for multiple comparison among SPSS groups); among those with MELD scores of 10-13, HE was reported in 48% with L-SPSS, 33% with S-SPSS, and 23% with W-SPSS (P < .001 for multiple comparison among SPSS groups); among patients with MELD scores of 14 or more, HE was reported in 59% with L-SPSS, 57% with S-SPSS, and 48% with W-SPSS (P = .043 for multiple comparison among SPSS groups). Patients with SPSS and MELD scores of 6-9 were at higher risk for ascites (40.5% vs 23%; P < .001) and bleeding (15% vs 9%; P = .038) than patients W-SPSS and had lower odds of transplant-free survival (hazard ratio 1.71; 95% confidence interval, 1.16-2.51) (P = .006). CONCLUSIONS: In a retrospective analysis of almost 2000 patients, we found 60% to have SPSS; prevalence increases with deterioration of liver function. SPSS increase risk for HE and with a chronic course. In patients with preserved liver function, SPSS increase risk for complications and death. ClinicalTrials.gov ID NCT02692430.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Simón-Talero M, Roccarina D, Martínez J, et al. Association Between Portosystemic Shunts and Increased Complications and Mortality in Patients With Cirrhosis. Gastroenterology. 2018. PMID: 29360462. doi:10.1053/j.gastro.2018.01.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。